PFE - Viking Therapeutics gains amid renewed takeover speculation
2024-02-16 12:34:51 ET
More on Viking Therapeutics
- Viking Therapeutics, Inc. (VKTX) Q4 2024 Earnings Call Transcript
- Evaluating Viking's Position In The GLP-1/GIP Agonist Race
- Biotech And Pharma Diversification Pays Off
- Viking Therapeutics GAAP EPS of -$0.25 beats by $0.01
- Viking Therapeutics gains amid takeover speculation